Emergent BioSolutions Stock Storms Higher After The FDA Signs Off On Mpox Vaccine

byiShook Opinion
Aug 30, 2024 - 11:20

Share

The FDA approved a supplemental application to expand Emergent BioSolutions' existing smallpox vaccine to include Mpox. The post Emergent BioSolutions Stock Storms Higher After The FDA Signs Off On Mpox Vaccine appeared first on Investor's Business Daily.

The FDA approved a supplemental application to expand Emergent BioSolutions' existing smallpox vaccine to include Mpox.

The post Emergent BioSolutions Stock Storms Higher After The FDA Signs Off On Mpox Vaccine appeared first on Investor's Business Daily.